International Biomedical Devices, Inc. Appoints Mark Packer, MD as Chief Medical Officer
Internationally Recognized Leader in Cataract and Refractive Lens Surgery Brings Expertise to Early-Stage Medical Device Company
Mount Pleasant, SC- June 15, 2015- International Biomedical Devices, Inc. (IBMD), an early-stage medical device company focused on the emerging, non-laser based, precision capsulotomy category for cataract surgery, today announced the appointment of Mark Packer, M.D. as the company’s chief medical officer (CMO).
IBMD’s flagship product, the ApertureRx™ Precision Capsulotomy System (ApertureRx), is designed to create a precise incision during a cataract procedure, and simplify capsulotomy creation. This innovative technology may increase the safety of the procedure, and create more predictable visual outcomes for the patient. By simplifying the current manual procedure, a broader range of surgeons throughout the world will be able to achieve surgical incisions with precise placement and a high degree of consistency.
“ApertureRx is a simple, elegant, low cost solution for constructing a perfectly round, predictable capsulotomy,” said Mark Packer, MD “Cataract surgeons see its advantages immediately. I’m excited to join the executive team at IBMD and put ApertureRx into surgeons’ hands.”
Dr. Packer joins IBMD as an internationally recognized leader in ophthalmology, acknowledged as the author of original research establishing innovative techniques and groundbreaking technologies. He works extensively with leaders in the ophthalmic industry on the development of new technology, having served as principal investigator or medical monitor in more than 50 clinical trial protocols leading to numerous FDA clearances and approvals. Dr. Packer’s career demonstrates his dedication to improving care and enhancing outcomes through technological innovation. His goal remains increased safety and optimal results for all patients.
“We are delighted to welcome Dr. Packer to IBMD,” said Steven R. Bryant, Founder and CEO of IBMD. “His unparalleled experience and in-depth technical expertise in cataract
and refractive surgery will be of tremendous value to IBMD as we navigate through our clinical and regulatory milestones.”
A growing body of evidence indicates that a perfectly round capsulotomy during cataract surgery results in more precise sizing and centering, better IOL-capsule overlap parameters and less IOL tilt and decentration, ultimately leading to a more stable refractive result. Traditionally, the capsulotomy procedure is performed utilizing a manual technique. This technique requires a high-degree of skill and can sometimes lead to unpredictable results.
About International Biomedical Devices, Inc.
International Biomedical Devices, Inc. (IBMD) is an early-stage medical device company focused in ophthalmic innovations. At present the company is leading the emerging, non-laser based, precision capsulotomy category through the development of a unique and much-needed new capsulotomy technology. The arrival of this device represents a considerable potential improvement to traditional surgical technique by ensuring safer, more precise cataract surgeries and more predictable outcomes for patients.
# # #
Pascale Communications, LLC